ArticleInternational journal of molecular sciences2022

A Novel CDK4/6 and PARP Dual Inhibitor ZC-22 Effectively Suppresses Tumor Growth and Improves the Response to Cisplatin Treatment in Breast and Ovarian Cancer.

Chenchen Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.